Patent · US Active

Adjuvant compositions

US8580280B2 · kind B2 · utility

12Cited by

5References

32Claims

0Family size

Assignee

Zoetis LLC · US

Inventors

Paul Joseph Dominowski · Kalamazoo, US
Ramasamy Mannar Mannan · Woburn, US
Richard Lee Krebs · Ashland, US
James Richard Thompson · Portage, US
Tedd Alan Childers · Portage, US
Mary Kathryn Olsen · Kalamazoo, US
Robert John Yancey, Jr. · Richland, US
Risini Dhammika Weeratna · Ottawa, CA
Shucheng Zhang · Shanghai, CN
Cedo Martin Bagi · Branford, US

Key dates

Filing date	Jun 24, 2009
Grant date	Nov 12, 2013
Priority date	—
Expiry date	Jul 28, 2031

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to adjuvant formulations comprising various combinations of triterpenoids, sterols, immunomodulators, polymers, and Th2 stimulators; methods for making the adjuvant compositions; and the use of the adjuvant formulations in immunogenic and vaccine compositions with different antigens. This invention further relates to the use of the formulations in the treatment of animals.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.